"
Team:Utah State/Team
From 2012.igem.org
(Difference between revisions)
Cwbarentine (Talk | contribs) |
Cwbarentine (Talk | contribs) |
||
| Line 20: | Line 20: | ||
padding: 0;} | padding: 0;} | ||
#top-section { | #top-section { | ||
| - | width: | + | width: auto; |
height: 0; | height: 0; | ||
margin: 0 auto; | margin: 0 auto; | ||
| Line 27: | Line 27: | ||
#content { | #content { | ||
position: relative; | position: relative; | ||
| - | width: | + | width: auto; |
# margin-left: 10px; | # margin-left: 10px; | ||
margin: 0 auto; | margin: 0 auto; | ||
Revision as of 01:50, 8 September 2013
Antimicrobial Peptides
Antimicrobial peptides (AMPs) are peptides that have activity against a wide range of microorganisms. AMPs can vary greatly in their size, structure, and mode of antimicrobial activity. Due to the immense interest in both testing and characterizing AMPs (from various forms of life) a sustainable method to produce and purify them is necessary. Using Synthetic Biology as a platform, the production of AMPs in E.coli could potentially offer a cost-effective approach for large-scale peptide manufacture, as opposed to isolation from natural sources. After successfully manufacturing several AMPs using E.coli, these peptides will be tested on a wide variety of organisms to screen for antimicrobial activity.
